CASP3 and neoplasm: In cocultures of ES-2 cells with HLA-matched PBMCs, we found that BT and CUB treatment reduced EC50 values compared to monoculture and increased caspase 3/7 activity in a dose-dependent manner (Fig. 6b), indicating enhanced T cell-mediated tumor cell killing.